ICD-10-CM Billable Code

T39.396

Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID]

Clinical Classification Guidelines

Medical Intelligence & Overview

Underdosing of nonsteroidal anti-inflammatory drugs (NSAIDs) occurs when a person takes less medication than recommended. NSAIDs are commonly used to manage pain, inflammation, and fever. While appropriate dosing is essential for effective treatment, underdosing may lead to inadequate symptom relief and impact the management of various health conditions. Recognizing the importance of proper NSAID usage helps ensure safety and effectiveness in treatment plans.

Causes & Symptoms

Clinical Causes: Patient misunderstanding of dosage instructions Intentional reduction to avoid side effects, such as stomach irritation or cardiovascular risks Poor compliance due to forgetfulness or misunderstanding the importance of the full dose Initial conservative dosing recommended by a healthcare provider, later reduced without professional advice Limited access to medication or financial constraints leading to reduced intake

Key Symptoms: Persistent or worsening pain despite medication use Inadequate reduction of inflammation Continued swelling or discomfort where NSAIDs are indicated Potential development of secondary symptoms related to underlying conditions due to insufficient treatment Possible escalation of other medications if NSAID dosing is insufficient

Diagnostic & Treatment

Diagnosis Path: Diagnosis of underdosing of NSAIDs is primarily based on clinical assessment, patient history, and medication review. Healthcare providers evaluate patient reports of symptoms, medication adherence, and prescribed dosages. In some cases, dosage records, pharmacy refill histories, or patient diaries may assist in confirming underdosing. No specific laboratory test exists solely for this condition, but assessments may include monitoring inflammation markers or pain scales to gauge treatment adequacy.

Treatment Protocols: Addressing underdosing involves patient education on proper medication use, ensuring understanding of dosing schedules, and emphasizing the importance of adhering to prescribed amounts. Healthcare providers may adjust the medication regimen to optimize pain and inflammation control while minimizing side effects. Alternative strategies include exploring different NSAID formulations, recommending adjunct therapies for pain management, or evaluating for adverse effects that may lead to underuse. Close follow-up ensures that dosing remains appropriate and effective.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T39.396 a billable ICD-10 code?
Yes, T39.396 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T39.396?
Clinical documentation must specify the nature of Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] and any associated comorbidities for accurate reporting.

Cite this Clinical Reference